Cervical cancer patients were significantly more likely to be alive and cancer-free after five years when given a short course of chemotherapy prior to chemoradiation. This is the finding of a clinical trial led by researchers ...
Oct 15, 2024
0
37
With ongoing advancements in cervical cancer research, the global scientific community has gained a more comprehensive understanding of this significant threat to women's health.
Oct 10, 2024
0
0
A study led by researchers at Queen Mary University of London reveals women would welcome the option to choose between self-sampling and traditional screening done by a nurse or doctor for human papillomavirus (HPV)-based ...
Oct 10, 2024
0
0
A study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. The study is published in the October 9, 2024, online issue of Neurology. Types of cancers found ...
Oct 9, 2024
0
0
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modeling in Canadian Medical Association Journal.
Oct 7, 2024
0
0
U.S. cancer incidence trends improved in 2021, but continued to be lower than expected, according to a study published online Sept. 6 in JAMA Network Open.
Sep 8, 2024
0
0
Women in China are now healthier than ever, but as the economy grows and China's culture becomes more westernized, the country faces new challenges due to changing social norms and expectations, say experts in a special collection ...
Aug 30, 2024
0
0
Girls with mental illness or neurodevelopmental conditions are less likely than their peers to be vaccinated with the HPV vaccine that protects against future cervical cancer. This is according to a new registry study by ...
Aug 29, 2024
0
23
Cervical cancer, the fourth most common cancer type in women, causes approximately 350,000 deaths each year, mainly in middle- and low-income countries. Human papillomavirus (HPV) infection is known to cause 95% of these ...
Aug 23, 2024
0
36
Socioeconomic status, provider-patient relationships and rural living environments have been found to affect cancer screening behaviors for people LBGTQIA+ individuals, according to a recent study from Callie Kluitenberg ...
Aug 15, 2024
0
36
Cervical cancer is the term for a malignant neoplasm arising from cells originating in the cervix uteri. One of the most common symptoms of cervical cancer is abnormal vaginal bleeding, but in some cases there may be no obvious symptoms until the cancer has progressed to an advanced stage. Treatment usually consists of surgery (including local excision) in early stages, and chemotherapy and/or radiotherapy in more advanced stages of the disease.
Cancer screening using the Pap smear can identify precancerous and potentially precancerous changes in cervical cells and tissue. Treatment of high-grade changes can prevent the development of cancer in many victims. In developed countries, the widespread use of cervical screening programs has reduced the incidence of invasive cervical cancer by 50% or more.[citation needed]
Human papillomavirus (HPV) infection appears to be a necessary factor in the development of almost all cases (90+%) of cervical cancer. HPV vaccines effective against the two strains of this large family of viruses that currently cause approximately 70% of cases of cervical cancer have been licensed in the U.S, Canada, Australia and the EU. Since the vaccines only cover some of the cancer causing ("high-risk") types of HPV, women should seek regular Pap smear screening, even after vaccination.
The cervix is the narrow portion of the uterus where it joins with the top of the vagina. Most cervical cancers are squamous cell carcinomas, arising in the squamous (flattened) epithelial cells that line the cervix. Adenocarcinoma, arising in glandular epithelial cells is the second most common type. Very rarely, cancer can arise in other types of cells in the cervix.
This text uses material from Wikipedia licensed under CC BY-SA
